{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:21:15Z","timestamp":1788870075746,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Program of the National Institute of Mental Health, National Institutes of Health (IRP\u2010NIMH\u2010NIH)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.schres.2012.07.021","type":"journal-article","created":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T12:15:48Z","timestamp":1345378548000},"page":"185-188","source":"Crossref","is-referenced-by-count":45,"title":["Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia"],"prefix":"10.1016","volume":"141","author":[{"given":"Kimberly J.","family":"Jenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioline D.","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacey B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami S.","family":"Zoghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Deep-Soboslay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel E.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.schres.2012.07.021_bb0005","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2011.43","article-title":"Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex","volume":"36","author":"Dalton","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2012.07.021_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.schres.2012.07.021_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12264-007-0051-9","article-title":"No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia","volume":"23","author":"Deng","year":"2007","journal-title":"Neurosci. Bull."},{"issue":"18","key":"10.1016\/j.schres.2012.07.021_bb0020","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1021\/jm800416m","article-title":"Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging","volume":"51","author":"Donohue","year":"2008","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.schres.2012.07.021_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control. Clin. Trials"},{"issue":"7","key":"10.1016\/j.schres.2012.07.021_bb0030","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2012.07.021_bb0035","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/npp.2010.75","article-title":"Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: comparison of schizophrenia and major depressive disorder","volume":"35","author":"Eggan","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2012.07.021_bb0040","doi-asserted-by":"crossref","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","article-title":"A flexible and accurate genotype imputation method for the next generation of genome-wide association studies","volume":"5","author":"Howie","year":"2009","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.schres.2012.07.021_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.schres.2012.07.021_bb0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.65.7.841","article-title":"The incentive salience of alcohol: translating the effects of genetic variant in CNR1","volume":"65","author":"Hutchison","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2012.07.021_bb0055","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00702-007-0660-5","article-title":"Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression","volume":"114","author":"Koethe","year":"2007","journal-title":"J. Neural Transm."},{"issue":"6","key":"10.1016\/j.schres.2012.07.021_bb0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.biopsych.2006.06.019","article-title":"Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia","volume":"60","author":"Lipska","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2012.07.021_bb0065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","article-title":"Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia","volume":"172","author":"Newell","year":"2006","journal-title":"Exp. Brain Res."},{"issue":"8","key":"10.1016\/j.schres.2012.07.021_bb0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00259-010-1411-7","article-title":"Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography","volume":"37","author":"Terry","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.schres.2012.07.021_bb0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-009-1608-2","article-title":"Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment","volume":"206","author":"Uriguen","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.schres.2012.07.021_bb0080","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.neuroimage.2010.04.034","article-title":"Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR","volume":"52","author":"Wong","year":"2010","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.schres.2012.07.021_bb0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641200415X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641200415X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T05:57:35Z","timestamp":1542779855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641200415X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":17,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S092099641200415X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2012.07.021","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}